Jacob Galson

Jacob Galson is a multidisciplinary scientist who has accumulated significant technical and management experience in the fields of immunology, bioinformatics, and software development, particularly in the context of drug discovery. He holds a Doctor of Philosophy (PhD) in Paediatrics and a First Class BA in Biological Sciences, both from the University of Oxford.

Throughout his career, Jacob has held key positions in various organizations, including his current role as Head Of Technology at Alchemab Therapeutics Ltd. Prior to this, he served as the Director Of Technology at the same company. He also has experience as a Team Leader in Bioinformatics and as a Research Scientist with project leadership responsibilities.

Jacob's career journey includes valuable stints at Kymab Ltd, where he held roles as a Research Scientist, Team Leader, and IntelliSelect Project Leader. He also worked as a Postdoc at the University of Zurich and as a Research Scientist at Oxitec Ltd. Additionally, he gained experience as a PhD student at both GSK and the University of Oxford, showcasing his continuous dedication to learning and research in the scientific realm.